Digestive System Neoplasms  >>  pioglitazone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00867126: Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Terminated
1
6
US
pioglitazone hydrochloride, laboratory biomarker analysis, questionnaire administration, quality-of-life assessment
University of Texas Southwestern Medical Center
Pancreatic Cancer
02/12
02/12

Download Options